EVOGENE
Evogene utilizes computational biology technologies to revolutionize life-science product development. Its CPB (Computational Predictive Biology) platform incorporates deep scientific understanding with big data and advanced artificial intelligence (AI) technologies. The CPB platform optimizes the probability of success and reduces time and cost during the development process.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-08-07 | Lavie bio | Evogene investment in Corporate Round - Lavie bio | 27 M USD |